1994 Volume 42 Issue Supplement4 Pages 743-745
We evaluated the clinical effecacy and safety of biapenem (BIPM), a new injectable carbapenem antibiotic. BIPM was used to 9 patients. Clinical response was excellent in 2, good in 6, fair in 1patients.
Adverse reactions were not observed. Abnormal laboratory values were noted in 1 patient (GPT) but was not clinically significant.